Synektik S.A. Cash Flow Conversion Efficiency

Latest as of December 2025: 0.376x

Synektik S.A. cash flow conversion efficiency. Based on the latest financial reports, Synektik S.A. (SNT) has a cash flow conversion efficiency ratio of 0.376x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł97.11 Million ≈ $26.73 Million USD) by net assets (zł258.34 Million ≈ $71.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Synektik S.A. (2010–2025)

Cash flow conversion efficiency of Synektik S.A. from 2010 to 2025. This chart illustrates how Synektik S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Synektik S.A. stock quote for real-time trading data and today's change.

Synektik S.A. Cash Flow Conversion Ratio Explained

Synektik S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Synektik S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Synektik S.A. ranked by their cash flow conversion efficiency. Also see SNT company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Aeroflex Industries Limited
NSE:AEROFLEX
0.020x
WELL Health Technologies Corp
TO:WELL
0.090x
Eagle Bancorp Inc
NASDAQ:EGBN
-0.030x
Xi'an Manareco New Materials Co.Ltd
SHG:688550
0.043x
National Grid PLC
LSE:NG
0.087x
Hangzhou Raycloud Technology Co Ltd
SHG:688365
0.018x
Jutze Intelligent Technology Co Ltd
SHE:300802
0.021x
Shanghai Anoky Group
SHE:300067
-0.006x

Annual Cash Flow Conversion Efficiency for Synektik S.A. (2010–2025)

The table below shows the annual cash flow conversion efficiency of Synektik S.A. from 2010 to 2025. Review SNT free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 zł223.54 Million
≈ $61.52 Million
zł78.29 Million
≈ $21.55 Million
0.350x -25.73%
2024-12-31 zł190.02 Million
≈ $52.30 Million
zł89.61 Million
≈ $24.66 Million
0.472x -33.03%
2023-12-31 zł134.20 Million
≈ $36.93 Million
zł94.49 Million
≈ $26.01 Million
0.704x +1100.26%
2022-12-31 zł87.85 Million
≈ $24.18 Million
zł-6.18 Million
≈ $-1.70 Million
-0.070x -126.12%
2021-12-31 zł80.56 Million
≈ $22.17 Million
zł21.71 Million
≈ $5.97 Million
0.269x +47.05%
2020-12-31 zł76.00 Million
≈ $20.92 Million
zł13.93 Million
≈ $3.83 Million
0.183x -4.96%
2019-12-31 zł70.25 Million
≈ $19.33 Million
zł13.55 Million
≈ $3.73 Million
0.193x +128.79%
2018-12-31 zł61.99 Million
≈ $17.06 Million
zł5.22 Million
≈ $1.44 Million
0.084x -64.30%
2017-12-31 zł61.72 Million
≈ $16.99 Million
zł14.57 Million
≈ $4.01 Million
0.236x +266.76%
2016-12-31 zł56.94 Million
≈ $15.67 Million
zł-8.06 Million
≈ $-2.22 Million
-0.142x -239.90%
2015-12-31 zł56.55 Million
≈ $15.56 Million
zł5.72 Million
≈ $1.57 Million
0.101x -50.65%
2014-12-31 zł58.33 Million
≈ $16.05 Million
zł11.96 Million
≈ $3.29 Million
0.205x +78.34%
2013-12-31 zł55.93 Million
≈ $15.39 Million
zł6.43 Million
≈ $1.77 Million
0.115x -23.80%
2012-12-31 zł17.67 Million
≈ $4.86 Million
zł2.67 Million
≈ $733.93K
0.151x -61.33%
2011-12-31 zł18.32 Million
≈ $5.04 Million
zł7.15 Million
≈ $1.97 Million
0.390x +228.82%
2010-12-31 zł3.36 Million
≈ $924.38K
zł-1.02 Million
≈ $-280.09K
-0.303x --

About Synektik S.A.

WAR:SNT Poland Medical Devices
Market Cap
$767.58 Million
zł2.79 Billion PLN
Market Cap Rank
#9718 Global
#52 in Poland
Share Price
zł327.00
Change (1 day)
-1.74%
52-Week Range
zł248.20 - zł394.00
All Time High
zł394.00
About

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more